CXCL14 and Sepsis: Future studies utilizing animal models of systemic infection like sepsis could reveal the antimicrobial potential of CXCL14 not only as a therapeutic alternative administered to these models but decipher the role of active immune cell derived CXCL14 in providing antimicrobial defence under physiological conditions.